Preterm Birth Diagnostic Test Kits Market Projected to Reach US$ 200 Mn By 2028

A new study by the company titled 'Preterm Birth Diagnostic Test Kits Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018–2028', has listed out the key points being considered by preterm birth diagnostic test kits companies to emerge and stay sustainably profitable in the long run in the preterm birth diagnostic test kits market. The global preterm birth diagnostic test kits market is expected to expand at a CAGR of 7.4% over the forecast period to reach a value of over US$ 200 Mn by 2028, and the North America preterm birth diagnostic test kits market is expected to remain as a main sink market for revenues. Europe is expected to remain as the main source market for preterm birth diagnostic test kits, as most of the preterm birth diagnostic test kits facilities are located in this region. However, with the increasing demand and cost-effective diagnostic options in countries such as China and India, and various countries of Asia Pacific and Middle-East, is fueling the growth of preterm birth diagnostic test kits market.

Key Findings Presented in the Report on the Preterm Birth Diagnostic Test Kits Market

The report finds that approximately 115.4 million birthsoccurred in 2017, out of which 11.1% births were preterm, which is approximately 12.8 million births. As per WHO, preterm birth complications are the leading cause of deaths amongst children under the age of 5, directly responsible for approximately 1 million death in 2015. Out of these, 3/4th of these deaths can be prevented with cost-effective interventions. The adoption rates for preterm birth diagnostic tests kits ranged from 2% to 15% distributed over various geographies. Majority of the existent patient pool are unaware about the cost-saving benefits of preterm birth diagnostic test kits, thus, a major portion on the preterm birth test kits market has remained untapped which remains open for manufactures of preterm diagnostic test kits to exploit the preterm birth diagnostic test kits market over the forecast period.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7551

Analysis of the Preterm Birth Diagnostic Test Kits Market

For preterm birth diagnostic test kits, blood sample is the most common sample take for diagnosing preterm labor and premature rupture of membrane. Blood sample-based preterm birth diagnostic tests in preterm cases are the most common and widely accepted in the preterm birth diagnostic test kits end users. However, vaginal discharge sample type preterm birth diagnostic tests are gaining popularity for preterm birth diagnostic test kits.

Hospitals, outpatient clinics & diagnostic laboratories using preterm birth diagnostic tests are the primary point of contact for patients experiencing preterm birth symptoms. Hospitals are estimated to account for majority of the revenue share under the end users segment for preterm birth diagnostic test kits market in 2017, owing to being the primary healthcare facility for preterm cases. The prevalent cases of preterm birth, growing demand for cost-effective diagnostic options and preterm birth test kits, and success in clinical studies for developing a rapid preterm birth diagnostic test kits is expected to fuel the growth of the global preterm birth diagnostic test kits market over the forecast period.

Activities across the preterm birth diagnostic test kits manufacturers are restricted to efficiency and specificity testing. The top activity associated with preterm birth diagnostic test kits manufacturers is joint collaboration with various organizations in order to spread awareness, further development, and test the sensitivity, specificity and efficiency of preterm birth diagnostic test kits.

Factors Impacting Growth of the Preterm Birth Diagnostic Test Kits Market

Rising focus on cost-effective diagnosis using preterm birth diagnostic test kits is expected to boost the growth of the preterm birth diagnostic test kits market. Preterm birth diagnostic test kits manufacturing companies focusing on spreading awareness about preterm birth diagnostic test kits and marketing preterm birth diagnostic test kits through campaigns and joint research studies is expected fuel the growth of the preterm birth diagnostic test kits market during the forecast period. However, Preterm birth diagnostic kits experience stiff competition from alternative product lines. Trans-vaginal scans, advanced ultrasound are some of the examinations adopted by healthcare providers over preterm birth diagnostic kits and would pose challenges to the growth of the preterm birth diagnostic test kits market.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7551

Preterm Birth Diagnostic Test Kits Market: Companies

Some of the key preterm birth diagnostic test kits companies analyzed in this report titled Preterm birth diagnostic test kits market include Creative Diagnostics, Qiagen, Medixbiochemcia, Hologic Inc, Sera Prognostics, IQ Products, Biosynex, Nanjing Liming Biological Preparations Co Ltd, Clinical Innovations LLC, BIOSERV Diagnostics GmbH, Wuxi BioHermes Biomedical Technology Co. Ltd, and Anhui Deep Blue Medical Technology.

Actinic Keratosis Treatment Market to Reach US$ 8 Bn by 2028

Awareness programs by non-profit organization about the actinic keratosis treatment have increased the awareness level among the people about the actinic keratosis treatment in developed economies, which is consequently expected to increase the value of actinic keratosis treatment market. The company’s latest research on global actinic keratosis treatment market reflects the market to account for revenues over US$ 8 Bn, by 2028 end. The report on actinic keratosis treatment further projects significant growth potential with high single digit average year-on-year growth rate over the period of 2018-2028.

Overview of the Actinic Keratosis Treatment Market

In the U.S., actinic keratosis is estimated to affect 10% of females and 26.5% males, while the prevalence of actinic keratosis in the U.K. is 15% in males and 6% in females. Additionally, people with high fat diet also tend to be at high risk of actinic keratosis. Thus, increasing prevalence of actinic keratosis is a major factor expected to drive the growth of the actinic keratosis treatment market over the forecast period. The availability of large volume of clinical evidence data for the actinic keratosis treatment has increased awareness among patient base who want to participate effectively in their own treatment journey for faster relief. This has also helps physicians and prescribers to understand the success rate different options for the actinic keratosis treatment in isolation and also in combination which will upsurge the revenue growth of actinic keratosis treatment market. The flexibility to choose treatments, especially combination treatments for faster patient relief - due to availability of clinical evidence documentation are factors expected to propel treatment innovation and thus the revenue growth of the actinic keratosis treatment market over the forecast period.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-3233

Combination of topical fluorouracil and cryotherapy is the most commonly prescribed actinic keratosis treatment. The combination therapy of fluorouracil and cryotherapy for actinic keratosis treatment has success rate of around 90% for widespread multiple actinic keratosis lesion. This combination for actinic keratosis treatment has high success rate due to convenient administration, lower potential for irritation and systemic absorption of fluorouracil cream. Use of the fluorouracil cream for one week when combined with cryotherapy for actinic keratosis treatment improved outcomes versus cryotherapy alone, hence it is mostly prescribed by the medical professionals for better outcome of actinic keratosis treatment.

There are various options available for actinic keratosis treatment but the topical treatment is prescribed by the physicians as a first line of treatment. Topical medication for actinic keratosis treatment has a success rate of 25–60% in isolation, whereas photodynamic therapy is more successful in combination with various topical applications. Cost of topical medication for actinic keratosis treatment is much less compared to other options for actinic keratosis treatment, owing to which it has greater among preferred by the patients. Topical medication for actinic keratosis treatment includes gels and creams that can be self-prescribed and can be easily applied to the affected area of the body, which is also one of the reasons for the high preference of topical treatment for actinic keratosis. Besides, most of the topical creams and gels used for the actinic keratosis treatment are easily available in retail pharmacies and drug stores. Hence, topical treatment segment by product type for global actinic keratosis treatment market is expected to gain maximum market share in tem of value.

Actinic keratosis is a chronic skin disease, which can further transform to skin cancer, hence Medicare and Medicaid are providing reimbursements for the actinic keratosis treatment. Besides, various private health insurance companies in U.S. also reimburse the cost for actinic keratosis treatment. Medicare provides different CPT codes for the actinic keratosis treatment by different methods such as photodynamic therapy and cryotherapy. Favorable reimbursements scenario by Medicare and Medicaid are factors expected to boost the demand cryotherapy and photodynamic therapy for actinic keratosis treatment and in U.S. Therefore, North America is assessed to be most lucrative region for actinic keratosis treatment market. North America actinic keratosis treatment market is estimated to gain 34.8% market value share and anticipated to reach the market value of US$ 2,636.0 Mn by 2028.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-3233

Actinic Keratosis Treatment Market: Companies

The report tracks the key companies operating in the actinic keratosis treatment market, such as GlaxoSmithKline plc., Novartis AG, Nestle SA, Sun Pharmaceutical Ltd.,  Bausch Health Companies Inc., Almirall, LLC, LEO Pharma Inc., Pierre Fabre Pharmaceuticals, Inc., Biofrontera , Cipher Pharmaceuticals Inc.

Vision Care Market to Surpass US$ 127,730 Mn, in terms of value by 2028

The increasing usage of electronic devices, changing lifestyle and hygiene have led to vision-related problems worldwide. The number of patients with vision-related problems have increased and so is the need for vision care products and services. According to the latest report published by the company, the global vision care market size is projected to account for over US$ 127,730 Mn, in terms of value, by 2028 end. The report further projects significant growth with an average CAGR of 7.1% through 2028.

Vision Care Market: Dynamics

According to the World Health Organization (WHO), approximately 285 million people are visually impaired worldwide. Out of these, 39 million people are blind and 246 million people have low vision. Most of the disorders & conditions causing visual impairment & blindness are preventable or readily treatable with known & cost-effective interventions, and normal vision can be restored with the help of eyeglasses, contact lenses or refractive surgery. Ageing is one of the prime factors responsible for vision-related problems. Population aged 65+ years is growing day by day and with it the demand for eye care-related products and solutions is also increasing. This increasing ageing population and the growing demand for vision care products are factors expected to create growth opportunities for the manufacturers globally. Healthcare initiatives by the Federal health care programs have increased the number of population opting for vision care benefits. Besides, the out-of-pocket costs have reduced due to insurance coverage. Likewise, in the U.S., “The Patient Protection and Affordable Care Act” has defined eye care for pediatric as an essential benefit. This factor, in particular, is likely to play an instrumental role in driving the growth of the vision care market.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-822

With a rapid increase in the internet usage, technological changes and number of research-based industries, the usage of laptops, mobiles, PCs and others electronic devices has increased in the day-to-day life, which is the major factor responsible for eye-related problems. To overcome this alarming situation, "VISION 2020 - The Right to Sight” a global action program is conducted by NGOs and private organizations in collaboration with the WHO to prevent avoidable blindness. Also, “VISION 2020” has initiated global campaigns to raise awareness among governments about the societal effects of blindness and to gather a strong, long-term political & professional commitment to reduce avoidable blindness. “VISION 2020” has taken initiatives to develop & strengthen the primary health/eye care methodology to prevent the avoidable blindness.

The growth of the vision care market is driven by the increase in lens prescriptions and eye care professionals such as optometrists and ophthalmologists. Most of the ageing consumers (65+) have low awareness regarding eye health. Product development, particularly for the ageing population, is a major challenge as ageing consumers tend to suffer from dry eyes due to which fitting of contact lens becomes difficult. Therefore, the products for ageing consumers need more attention. Elderly population prefers spectacles over contact lens due to low awareness regarding their benefits. According to the company, the spectacle lenses segment accounted over 40% revenue share in the global vision care market in 2017. However, the growing popularity of contact lens might limit the segment’s growth in the near future. Contact lenses offer vision correction for the entire field of the eye including peripheral vision. Soft contact lenses are safe for daily use and for sports as well. They do not fog and can be discarded if damaged. Besides, they are economic compared to prescribed glasses.

Vision Care Market: Regional Insights

In Europe and Northern America, more than 1 person in 5 was aged 60 or above in 2017. According to a survey by the WHO, 90% of the visually impaired population is in low- & middle-income countries. A significant share of this population is unaware regarding the preventive care for vision loss, available curative services and quality rehabilitation. Further, the growing number of ageing population with vision disorders in Asia Pacific is likely to boost the growth of the vision care market in Asia Pacific. Increasing geriatric population and rising disposable income in North America is expected to surge the demand for advanced vision care products and solutions. The North America vision care market is estimated to create an absolute $ opportunity worth US$ 21,735 Mn between 2018 and 2028.

Vision Care Market: Segmental Analysis

The company has segmented the global vision care market into spectacle lenses, contact lenses and cleaning & disinfecting solutions. In terms of revenue, the spectacle lenses and contact lenses segments are expected to hold significant shares over the forecast period. In contrary, the cleaning & disinfecting solutions segment in the vision care market is expected to exhibit limited investment opportunities, in terms of revenue, through 2028.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-822 

Vision Care Market: Companies

The report tracks some of the key companies operating in the vision care market, such as Bausch and Lomb (Acq. by Valeant Pharmaceuticals), Alcon (sub. Novartis AG), CooperVision and Johnson & Johnson, LUXOTTICA GROUP, Essilor, ZEISS International, Safilo Group and Rodenstock.

Global Cardiac Biomarker Diagnostic Test Kits Market to Reach US$ 2,540.8 Mn by 2028

According to the latest market report published by the company titled ‘Global Cardiac Biomarker Diagnostic Test Kits: Global Industry Analysis 2013–2017 and Opportunity Assessment, 2018–2028’, the global cardiac biomarker diagnostic test kits market is projected to expand at a CAGR of 5.1% during the forecast period 2018–2028 and reach US$ 2,540.8 Mn by the end of 2028.

Global Cardiac Biomarker Diagnostic Test Kits Market: Dynamics

Chest pain is a common emergency department (ED) presentation accounting for 8–10 million visits per year in the U.S. The increasing number of patient visits in the emergency department is expected to create growth opportunities for the cardiac biomarker diagnostic test kits market. Obesity has become a global health challenge in the past few decades, with every sixth person being obese. According to the WHO, the number of obese population around the globe has doubled in the last two decades. The growing obese population, which is at a high risk of developing cardiovascular diseases, is expected to consequently increase the demand for cardiac biomarker diagnostic test kits. Moreover, the leading manufacturers of cardiac biomarker diagnostic test kits are focusing on collaborating with universities and associations to develop and expand their product portfolio. On the other hand, less availability of novel cardiac biomarker diagnostic test kits due to tedious approval procedures is expected to hamper the growth of the cardiac biomarker diagnostic test kits market over the next decade.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-452

Global Cardiac Biomarker Diagnostic Test Kits Market: Forecast

The global cardiac biomarker diagnostic test kits market is segmented on the basis of product type, indication, end users and regions. On the basis of product type, the cardiac biomarker diagnostic test kits market has been segmented into Brain Natriuretic Peptide (BNPs) Test Kits, Creatine Kinase MB (CK-MB) Test Kits, Troponin (I&T) Tests Kits, Myoglobin Test Kits and other test kits. By product type, the BNP test kits segment dominated the global cardiac biomarker diagnostic test kits market with market value of US$ 682.9 Mn in 2017, and is expected to be the most lucrative segment throughout the forecast period. The BNP test kits segment in the global cardiac biomarker diagnostic test kits market is also projected to be the fast-growing segment, and to grow at CAGR of 6.8% over 2018–2028.

On the basis of indication, the cardiac biomarker diagnostic test kits market is segmented into Angina Pectoris, Acute Myocardial Infarction, Congestive Heart Failure, and others. By indication, the Angina Pectoris is expected to be the most lucrative segment in the cardiac biomarker diagnostic test kits market, and is estimated to account 45.2% value share in 2018 and to account for 41.4% value share by 2028 end, growing at a CAGR of 3.6%. The congestive heart failure segment by indication is expected to be the fast-growing segment in the cardiac biomarker diagnostic test kits market. The congestive heart failure segment is projected to grow at a CAGR of 6.7% over the forecast period to reach a market value of US$ 357.8 Mn by 2028.

On the basis of end users, the cardiac biomarker diagnostic test kits market has been segmented into hospitals, diagnostic laboratories, outpatient clinics, academic and research institutes. The diagnostic laboratories segment is expected to dominate the global cardiac biomarker diagnostic test kits market in 2018 as a large number of patients visit diagnostic laboratories for the diagnosis of cardiovascular disease. Revenue from the diagnostic laboratories segment is expected to increase at a CAGR of 5.9% over 2018–2028, to reach US$ 997.4 Mn by 2028.

On the basis of region, the cardiac biomarker diagnostic test kits market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, China, Japan and Middle East & Africa. North America dominated the global cardiac biomarker diagnostic test kits market with maximum value share in 2017. Chest pain is a common emergency department (ED) presentation in the region accounting for 8–10 million visits per year in the U.S., among which 20% of patients are diagnosed with the help of cardiac biomarker diagnostic test kits for cardiovascular diseases. One-third share of the cardiac biomarker diagnostic test kits market by value is accounted by the U.S. due to increasing prevalence of cardiovascular diseases and rising adoption of cardiac biomarker diagnostic test kits. APECJ is expected to be the fast-growing regional markets for cardiac biomarker diagnostic test kits due to increasing number of obese population and expansion strategies followed by the key manufacturers in the region. Latin America and MEA are expected to witness sluggish growth in the global cardiac biomarker diagnostic test kits market due to low awareness regarding the benefits of cardiac biomarker diagnostic test kits for the diagnosis of cardiovascular diseases.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-452

Global Cardiac Biomarker Diagnostic Test Kits Market: Competitive Landscape

Examples of some of the key players operating in the global cardiac biomarker diagnostic test kits market are Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Siemens AG, bioMérieux SA, Randox Laboratories Ltd. The global cardiac biomarker diagnostic test kits market is highly fragmented, with top six players, estimated to account for approximately 75% market share. Abbott Laboratories accounted maximum share of the global cardiac biomarker diagnostic test kits market in 2017, due to the acquisition of Alere Inc., which has helped the company to expand its product portfolio. Acquisition is the key strategy followed by all the leading manufacturers of cardiac biomarker diagnostic test kits market to expand their business. The companies of cardiac biomarker diagnostic test kits market are focusing on acquiring local manufacturers to expand their product portfolio and also to increase their market share.

MRI-guided Neurosurgical Ablation Market to Grow US$ 216.3 Mn by 2028

According to the latest market report published by Future Market Insights titled ‘MRI-Guided Neurosurgical Ablation Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028’, the global MRI-guided neurosurgical ablation market is projected to expand at a CAGR of 4.9% during the forecast period 2018–2028 and reach US$ 216.3 Mn by the end of 2028.

Global MRI-guided Neurosurgical Ablation Market: Dynamics

The per capita healthcare expenditure is currently following an uptrend across both developed and developing economies, which has made possible to implement quality patient care treatment options. The growing awareness regarding minimally surgery is expected to fuel the demand for MRI-guided neurosurgical system in the global market. The demand for MRI-guided neurosurgical system is primarily emanating from countries such as the U.S., Germany, the U.K. and Australia due to factors such as enhanced emergency room services coupled with affordability. 

According to a study published by the Oxford University in 2017, the overall incidence of brain cancer worldwide was 264,241 with prevalence of 5.57 per 100,000 people. The MRI-guided neurosurgical ablation system is more often used for the treatment of brain cancer, hence rising prevalence of brain cancer is expected to boost the growth of the market over the next decade. The MRI-guided neurosurgical ablation system requires a skilled neurosurgeon to perform the surgery efficiently, thereby shortage of neurosurgical workforce is a factor expected to hamper the growth of the MRI-guided neurosurgical ablation market.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-2514

Global MRI-guided Neurosurgical Ablation Market: Forecast

The global MRI-guided neurosurgical ablation market is segmented on the basis of product type, end users and regions. On the basis of product type, the global MRI-guided neurosurgical ablation market has been segmented into MRI-guided laser therapy systems, MRI-guided RF ablation systems, MRI-guided focused ultrasound system and accessories. The MRI-guided ultrasound focused system segment is expected to grow at a significant rate as the use of the system omits the need of an incision, which is required during the surgical procedure. The accessories segment is expected to dominate the global MRI-guided neurosurgical ablation market due to increasing adoption of minimally invasive surgery throughout the globe. The MRI-guided laser therapy systems segment is projected to witness significant growth compared to the MRI-guided RF ablation systems segment, and to reach the market value of US$ 30.9 Mn by 2028 with a CAGR of 4.0% over the forecast period.

On the basis of end users, the MRI-guided neurosurgical ablation market has been segmented into hospitals, ambulatory surgical centers and research laboratories. The hospitals segment is expected to dominate the global MRI-guided neurosurgical ablation market in 2018 as a large number of patients visit hospitals for the treatment of brain cancer. The ambulatory surgical center segment is estimated to account a high value share of 33.0% of the global MRI-guided neurosurgical ablation market by 2018 end and is expected to account for 30.2% share of the global MRI-guided neurosurgical ablation market by 2028 end.

On the basis of region, the MRI-guided neurosurgical ablation market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, China, Japan and Middle East & Africa. North America dominated the global MRI-guided neurosurgical ablation market with maximum value share in 2017, as MRI-guided neurosurgical ablation system were installed in more than 70 hospitals in the U.S. One-third of MRI-guided neurosurgical ablation market share by value is accounted by the U.S. due to increasing prevalence of cancer and rising adoption of minimally invasive surgeries. China and APECJ are the fast-growing regional markets for MRI-guided neurosurgical ablation due to rising prevalence of brain cancer and expansion strategies followed by the key manufacturers in the regions. Latin America and MEA are expected to witness sluggish growth in the global MRI-guided neurosurgical ablation market due to low awareness regarding MRI-guided neurosurgery and lack of medical professionals.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-2514

Global MRI-guided Neurosurgical Ablation Market: Competitive Landscape

Examples of some of the top players operating in the global MRI-guided neurosurgical ablation market are Medtronic plc, Boston Scientific Corporation, Insightec Lmt, AngioDynamics Inc, Monteris Medical Inc, and MRI Intervention Inc. Maintaining and expanding international presence is an important long-term growth strategy of the leading manufacturers of MRI-guided neurosurgical ablation system. In addition, the manufacturers of MRI-guided neurosurgical ablation systems are investing in the emerging markets to strengthen their sales and service capabilities and gain maximum market share.

Wearable Sleep Trackers Market to Witness a Rise of US$ 3,072.0 Mn by 2028

Future Market Insights delivers key insights on the global wearable sleep tracker market in its upcoming report titled “Wearable Sleep Trackers Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global wearable sleep tracker market is projected to register a CAGR of 7.6% over the forecast period, owing to various factors, regarding which FMI offers detailed insights and forecasts in this report.

The global wearable sleep tracker market is segmented based on product type, application, distribution channel and regions. Based on product type, the global wearable sleep tracker market is segmented into wearable sleep tracker ring devices, wearable sleep tracker wristband and hand band devices, wearable sleep tracker headband devices and sleep mask tracker devices. The wearable ring devices is expected to be the leading segment in the global wearable sleep tracker market, and is projected to grow at a CAGR of 9.5% over the forecast period.

Based on application type, the global wearable sleep tracker market is segmented into insomnia, sleep apnoea and others. The others segment (including wellness application) in the global wearable sleep tracker market is expected to account a high revenue share and grow at a CAGR of 7.1% over the forecast period. Based on distribution channel, the global wearable sleep tracker market is segmented into pharmacy and retails stores, online sales, hypermarkets and supermarkets and others. The online sales in the global wearable sleep tracker market is expected to be the leading segment, and is expected to grow at a CAGR of 7.9% over the forecast period.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-6007

The growth of the global wearable sleep tracker market is primarily driven by increasing incidence of sleep disorders such as insomnia and sleep apnoea globally, availability of different types of wearable sleep trackers and growing awareness regarding sleep-related ailments and importance of a healthy sleep. Likewise, the number of new cases of sleep disorders have increased globally owing to the rise in obese and geriatric population and increase in unhealthy habits leading to unhealthy lifestyle. Different types of wearable sleep tracker devices are present in the market with different price ranges and fitness requirements. Besides, awareness regarding healthy sleep is also growing due to several educational programs and availability of information on the internet on conditions such as insomnia and sleep apnoea. Several sleep foundations such as the National Sleep Foundation are consistently spreading awareness regarding sleep disorder symptoms, diagnosis and treatments available.

There is a consistent growth in the healthcare expenditure in developed regions such as North America, Western Europe and Japan owing to increased incidence and prevalence of health-related problems and sleep disorders. Besides, growth in disposable income has contributed to an increase in wellness penetration, which has led to the growth of the market for wearable sleep tracker. Improved wearable sleep tracker technologies and better aesthetics are also expected to drive the growth of the wearable sleep trackers market over the forecast period.

This report assesses the trends that are driving the growth of each segment of the wearable sleep tracker market on the global as well as regional level, and offers potential takeaways that could prove substantially useful to the manufacturers planning to enter the wearable sleep tracker market.

North America accounted a high revenue share in 2017 and is expected to be the dominant regional market for wearable sleep tracker over the forecast period. The U.S. wearable sleep tracker market is expected to hold a large share in North America and is expected to grow at a CAGR of 5.1% over the forecast period. China and Asia Pacific excluding China & Japan wearable sleep tracker markets are anticipate to exhibits with double digit CAGRs over the forecast period.

Examples of some of the key players covered in the report of the wearable sleep tracker market are Fitbit, Inc., Garmin Ltd., Koninklijke Philips N.V., Huami Corporation, Fossil Group, Inc., and Huawei Technologies Co., Ltd., among others. The companies are focusing on developing novel wearable technologies. However, the higher cost associated with certain wearable sleep trackers and lack of standardization of these devices might hinder the growth of the wearable sleep trackers market over the forecast period.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-6007

In this report, we have discussed the individual strategies followed by these companies regarding the improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report has been concluded with the key takeaways of the players present in the market and the new players planning to enter the market.

Use of Membrane Microfiltration to Improve the Shelf Life of Milk Trending the Global Market, Says Future Market Insights

Several traditional techniques such as pasteurisation, heat treatment, and sterilisation have long been used to improve the shelf life of milk. One of the newest alternatives to heat treatment is microfiltration that reduces bacteria and improves the shelf life of dairy products, while also preserving the basic taste. Adoption of membrane microfiltration in milk is one of the trends being witnessed in the global market, according to a new research study on the global membrane microfiltration market by Future Market Insights. An increasing adoption of ceramic microfiltration membranes for cross flow filtration in water plants is another key trend, as ceramic membranes help maintain a high filtration rate and ensure enhanced savings in membrane replacement costs.

Manufacturers in the membrane microfiltration market are producing robust microfiltration systems using large filter cartridges that occupy lesser space and eliminate the number of filtration system connections, thereby reducing maintenance costs. A preference for continuous fermentation over batch processing is also being observed, with manufacturers increasingly deploying membrane microfiltration technology in their plants. These trends are likely to positively impact revenue growth of the global membrane microfiltration market in the coming years. According to Future Market Insights forecasts, sales revenue in the membrane microfiltration market is anticipated to cross US$ 8 Bn by 2028, from an estimated value of about US$ 3.8 Bn in 2018. A decadal growth rate of 7.8% can be attributed to several factors, of which Future Market Insights throws deeper insights in this research study.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-5402

Increasing Applications in Industrial Biotechnology and Widespread Use of Large Molecule Biopharmaceuticals Pushing Revenue Growth of the Global Membrane Microfiltration Market

Membrane microfiltration is finding application in the production of biofuel and bio refineries are incorporating this technology to lower the overall energy costs and reduce industrial bio waste. Membrane microfiltration is also increasingly used in biodiesel processes where this technology is used to reuse water especially in areas of water scarcity. The rising industrial applications of membrane microfiltration are fuelling revenue growth in the global market. Also, filtration is a critical component of biopharmaceuticals production, and membrane microfiltration is widely used to remove cellular debris and other cellular colloids. With a growing adoption of large molecule biopharmaceuticals owing to their therapeutic properties, the demand for membrane microfiltration technology in the production of biopharmaceuticals is expected to surge in the near future.

Membrane microfiltration is also extensively used in the food and beverages industry as a technology to separate and purify components and improve the quality and yield of food products. An increasing use in vegetable and fruit juices, fermented dairy products, milk and dairy products, non-alcoholic beverages, and other food and beverage products is expected to spur revenue growth of the global membrane microfiltration market to a significant extent. One of the other critical application areas of membrane microfiltration is in water treatment plants. Membrane microfiltration helps remove unwanted particles from water before the water is treated for purity using other processes such as reverse osmosis. A growing need for quality potable water is further driving growth of the membrane microfiltration market.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-5402

Future Market Insights Recommends…

With newer applications of membrane microfiltration coming to the fore, Future Market Insights feels there is a great deal of opportunity for key players operating in the global market. Water treatment and food and beverages are two important end-use application areas that manufacturers can target with their advanced solution offerings. China is projected to be the fastest growing regional market for membrane microfiltration in terms of demand for the technology, and manufacturers would be well advised to focus on this region to augment their market share. By setting up robust supply chains in regions that are anticipated to develop at a faster pace in the coming years, manufacturers can benefit from the lucrative opportunities presented by local markets to up their current standing in the global membrane microfiltration market.

Shift Towards Dual Head Gamma Cameras and Premium Priced Hi-tech Products Trending the Mobile Gamma Cameras Market

Advancements in healthcare technology - particularly in the surgery category - have led to an increasing adoption of gamma cameras. Further, the numerous developments in radio nucleotides are anticipated to favour the adoption of solid state cameras and mobile gamma cameras. SPECT is currently the biggest application of gamma cameras given the low cost, large suite of radioisotopes, and expanded use cases. Having said this, PET is anticipated to witness fastest growth in terms of adoption, owing to the greater special resolution and sensitivity, brought about by the use of positron emitting radioisotope that provides more energy, contrast, and special resolution. These findings are presented in a new research study on the global mobile gamma cameras market by Future Market Insights (FMI).

According to FMI analysis, the high costs of PET as compared to SPECT are expected to be negated in the wake of development of high sensitivity and selective tracers. FMI predicts a growth rate of 4.8% for the mobile gamma cameras market during the 10 year period from 2018 to 2028. Revenue from the sales of mobile gamma cameras is estimated to reach US$ 75.2 Mn by 2028 end, up from US$ 47.2 Mn in 2018.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7368

Shift Towards Dual Head Gamma Cameras and Premium Priced Hi-tech Products Trending the Mobile Gamma Cameras Market

Technology continues to remain a major enabler of revenue growth in the global mobile gamma cameras market. Being a high value-low volume market, technology plays a vital role in the mobile gamma cameras market, where the technologically advanced products are priced at a premium. The development of solid state sensors is slowly replacing the photomultiplier tube and this represents the biggest technological development in the mobile gamma cameras market followed by miniaturisation.

A notable trend being observed in the mobile gamma cameras market is the adoption shift towards dual head gamma cameras. Single head mobile gamma cameras have certain inherent disadvantages such as slow speed and lower density count leading to inability to perform different types of tests. This has resulted in an elevated demand for multiple head cameras. Dual head cameras increase total counts per stop, resulting in relatively lesser scan time and better image quality leading to enhanced accuracy in diagnosis.

Further, the latest mobile gamma cameras come with newer and better functionalities. Owing to advances in electronic components and software, modern mobile gamma cameras include advanced reconstruction algorithms and periodic updates that help boost scan speeds and image correction parameters. Advanced gamma camera software also facilitates more personalised patient scans by tracking patient activity and performing appropriate scans.

Key Takeaways from the Research Study on Mobile Gamma Cameras

The report by Future Market Insights studies the growth trajectory of the global market for mobile gamma cameras and also presents detailed forecasts for the various segments of the market. 

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7368

Key insights from the report are highlighted below:

• Ambulatory surgical centres will remain fastest growing end users of mobile gamma cameras, owing to a greater demand in point of care testing
• North America represents the largest regional market for mobile gamma cameras while Asia Pacific is expected to be the fastest growing market
• Single head mobile gamma cameras continue to remain dominant in terms of revenue owing to the small form factor and low cost; however, dual head mobile gamma cameras will witness rapid growth in demand on account of their high scanning speeds and better resolution
• New product development and strong after sales service agreements with end users will remain key differentiating strategies of mobile gamma camera manufacturers

Western Blotting Processors Market to Grow US$ 329 Mn by 2028

Conventional western blotting processors are relatively inconsistent in terms of the efficiency of detecting protein traces in samples. While the technique of western blotting demands time and technical expertise, automation has magnified the process of throughput screening in western blotting, thereby facilitating increasing number of trials and accelerating the experimentation process. Automated western blotting techniques enable the analysis of several samples at one go, with the only manual task being loading of the sample into the western blotting system. Automation is currently trending the western blotting processors market, as revealed in a comprehensive research study by Future Market Insights.

From an estimated valuation of US$ 200 Mn in 2018, the western blotting processors market is projected to reach a market value of just under US$ 329 Mn towards the close of 2028, exhibiting a decadal CAGR of 5.1%, according to the research report by Future Market Insights.

Manufacturers of Western Blotting Processors Accelerating Product Launches and Eyeing Offshoring as a Viable Growth Strategy

The market for western blotting processors is highly competitive with the top companies accounting for a larger part of global sales. Leading companies are acquiring smaller companies and expanding their production capacities to gain a larger share of the global market.

Companies in the western blotting processors market are leveraging the available market opportunities to launch their products in full gear in the global market. One of the market companies leveraged an unexploited demand for point-of-care HIV diagnostics as its key entry strategy in the western blotting processors market. Product registration followed by commercialisation is accelerating the product launch process and creating healthy competition in the global market for western blotting processors.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7365

Manufacturers of western blotting processors are setting up production facilities in other countries so as to benefit from access to cheap labour and resource expertise, and realign their distribution and customer oriented strategies. Another key player in the western blotting processors market recently made a strategic investment in the offshore development of its life sciences facility with a mandate to engage in the manufacturing and distribution of molecular biology products to a global clientele.

Increasing Global Cases of HIV and Expanding Applications Across Industries to Augment Revenue Growth of the Western Blotting Processors Market

The number of HIV cases across the world is increasing by the day, causing a burden on the global healthcare industry. Monitoring and controlling the HIV epidemic depends on early detection of anti-HIV antibodies in human blood. Western blot is a confirmed test that can detect anti-HIV antibodies in blood serum samples. This is one of the factors leading to an increase in the adoption of western blotting processors.

Proteomics is extensively used in the pharmaceuticals industry to identify specific proteins associated with particular diseases, with western blotting finding application in new drug discovery. In the field of medical diagnostics, proteomics is used in the diagnosis of biomarkers that are essentially proteins present in body fluids. Western blotting helps in quick diagnosis of diseases by identifying proteins that are produced when the human body contracts a disease. Besides the healthcare and pharmaceuticals industry, western blotting also finds application in the agriculture sector to establish protein characterisation in seed quality testing; and in the food and beverages industry to detect whey milk protein in commercial grade soy milk to check for possible adulteration. 

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7365

Western Blotting Processors Market Growth Challenged by High Costs, Low Innovation, and Unreliability of Automated Devices

Advanced automated western blotting devices such as the high performance western blotting transfer system are highly priced than their traditional counterparts, thereby restricting adoption across several developing economies. High cost of labour is another challenge in certain regions that continue to carry out protein tests using cheap traditional western blotting processors, thereby leading to time-consuming and high labour cost-inducing processes. Then again, the global western blotting processors market has not witnessed notable innovation, with very few advanced products launched in recent years. Further, results obtained from the western blotting process are not fully reliable or consistent and the devices need to be updated regularly to produce more efficient and reliable results. The aforementioned factors are challenging revenue growth of the global western blotting processors market.

Hearing Implant Market to Grow US$ 2 Billion by 2028

Loss of hearing is becoming a global cause of concern, with not only the geriatric population but also children suffering from hearing disabilities. Early intervention of hearing implants in children is becoming a trend, according to a new research on the hearing implant market published by leading research firm Future Market Insights. Expenditure on hearing impairment is a major liability on the global healthcare sector, and manufacturers of hearing implants are pushed to innovate hearing solutions that can provide accessible hearing care to the global population. Of the various products available in the global hearing implant market, cochlear implants are the most preferred, especially in the case of people with severe loss of hearing where hearing aids do not offer much benefit.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-492

Cochlear implants are recommended for patients whose inner ear sensory cells are severely damaged. These implants directly stimulate the auditory nerve and provide a sensation of sound, enabling patients with severe hearing loss to perceive sounds. Cochlear implants are the best option for enhanced hearing and are finding wide acceptance among the global medical fraternity. A promise of better hearing is boosting the adoption of hearing implants, thereby enhancing revenues in the global market. According to Future Market Insights’ analysis, the global hearing implant market is projected to be valued at about US$ 2 Bn by the end of 2028, up from an estimated US$ 996.2 Mn in 2018. This is indicative of a decadal growth rate of 7.5%.

Global Unmet Need of Hearing Implants and Technological Advancements in Hearing Solutions Key Opportunity Area for Manufacturers

The global market for hearing implants provides immense opportunities for companies, with the market faced with the need to manufacture affordable and functional hearing implants along with the provision of adequate follow-up services with audiologists. With the current production rate of hearing implants falling short of the global demand – especially when factoring in patients requiring bilateral implants – there is huge growth potential for both existing hearing implant manufacturers as well as new players. Further, considering that there are very few companies manufacturing hearing implants globally, there exists a lucrative revenue opportunity in the global hearing implant market.

Technological advancements in hearing care solutions are boosting global market demand for hearing implants. For instance, laser light technology is being incorporated in a new type of cochlear implants. Regular doctor follow-ups are mandatory post the initial programming of the hearing implant, and to simplify this process, a new remote feature is being developed, which enables patients to have regular follow-up programming sessions with their audiologists as and when required. One of the key players in the global hearing implant market has launched a Bluetooth wireless connectivity enabled device for patients opting for cochlear implants. By connecting to audio processors, this device helps patients acquire better hearing experiences.

High Cost Factor and Health Risks Arising from Surgical Procedures Restraining Revenues in the Global Hearing Implant Market

Hearing implants may come at increased prices, based on the functional complexity and extent of technology used. Further, being a surgical intervention, hearing implants result in additional costs such as surgery fees, medication, and hospitalisation costs. Hearing aids on the other hand are relatively cheaper and hence more affordable to all classes of people. High powered hearing aids are fast becoming popular owing to their ease of use and direct manageability by patients. Further, risks and complications arising from hearing implant surgeries is making patients opt for hearing aids. This is expected to restrict revenue growth of the hearing implant market.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-492

The global market for hearing implants is dominated by one company that holds about 55% of the total market revenue. This company manufactures a variety of products including bone conduction implants, middle ear implants, and auditory brainstem implants. This player has recently received FDA approval for remote programming in cochlear implants and is working on approvals and new technologies in hearing implants. 

Digital Radiography Detectors Market to reach a valuation of US$ 2,713.7 Mn by 2026

The global demand for digital radiography detectors is expected to grow at a robust pace over the eight-year forecast period, 2018-2026. As projected in a recently released market intelligence, Future Market Insights expects the global digital radiography detectors market to reach a valuation of US$ 2,713.7 Mn by 2026, exhibiting a promising 6.1% CAGR during 2018-2026.

Increase in number of radiography tests performed globally each year coupled with introduction of new and advanced imaging equipment by key market players will remain predominant factors pushing the demand for digital radiography detectors – with significant adoption of direct flat panel detectors. Moreover, considering distinct benefits over computed radiography (CR), charged couple detectors (CCD), and analog detectors (film based), digital radiography detectors are expected to witness high traction in the coming years.

New products that can be used to upgrade the current analog and CR detector systems to digital radiography systems—especially catering to small hospitals and imaging centers, is likely to accelerate the growth of digital radiography detectors market in the next eight years.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7238

North America and Europe are likely to remain the dominant regions in the digital radiography detectors markets, attributed to growing demand for X-ray Detectors and strong geographical presence of major manufacturers, respectively. Moreover, manufacturers of digital radiography detectors are increasingly focusing on launching products in emerging countries considering an unmet demand for digital radiography detectors and significant dependence on analog (film based) detectors.

The global market for digital radiography detectors is highly consolidated, with top players including Varex Imaging Corporation and Trixell holding close to 47% of the total market share. FMI expects key market players to focus on strategic acquisitions and collaboration and emphasis on cost effective product development, in addition to augmenting investments in product innovations and NPD.

A large number of players in the market are also investing in R&D and introduction of new products based on proprietary technologies, with focus on product differentiation. Moreover, shifting preference toward direct digital radiography (DDR) and a-Si detectors would present new market opportunities for emerging players working on innovative product offerings. Furthermore, imaging equipment manufacturers have an opportunity to improve their revenue stream by providing cloud storage services for medical imaging and information management, without scrapping of existing Picture Archiving and Communication (PACS).

Promising benefits of using indirect conversion technique of the digital radiography (DR) technology which involves use of amorphous silicon (a-Si) photodiodes and cesium iodide (CsI) scintillators for X-ray detection is projected to drive the adoption of digital radiography detectors. The benefits of Si X-ray detectors, mostly used in dental CBCT and orthopedic imaging includes lower patient radiation dose, reduced exam time, lower noise, and increased efficiency. More advanced applications in Mammography imaging and breast CT have pushed key players to expand their product offerings, with designs and technologies specific to aforementioned imaging.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7238

However, high cost of C-arms compared to traditional X-Ray systems could inhibit the adoption of Fluoroscopy Imaging Systems, especially in low and middle income countries with lower rate of healthcare expenditure. Additionally, new technologies with improved benefits such as improved spatial image resolutions, better image quality owing to lower pixel imaging, and increased cost-benefit ratios are projected to restrict the growth of digital radiography detectors market.

Carpal Tunnel Release Systems Market: Open CTR Systems to Remain Largest Product Type Through 2028

Increased awareness among patients suffering from carpal tunnel syndrome, apropos of carpal tunnel surgeries is projected to drive the global market for carpal tunnel release (CTR) systems, over the forecast period of 2018-2028. Moreover, the success rate of carpal tunnel release procedures would also fuel the demand for carpal tunnel release systems through 2028.  Future Market Insights (FMI), in its recently released intelligence outlook on the global market for carpal tunnel release systems, forecasts steady growth for the market over the next 10 years.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-5965

During 2018-2028, the global revenue of carpal tunnel release systems market is anticipated to expand at a steady CAGR of 5.5% and reach a market valuation worth US$ 839.1 Mn by the end of 2028. The Endoscopic CTR systems segment is expected to grow at a high CAGR compared to open CTR systems throughout the forecast period. The demand for carpal tunnel release systems is primarily emanating from North America, followed by Western Europe—both also holding the maximum revenue share in the global CTR systems market. Affordable and better equipped emergency rooms are contributing to the growing demand for better quality surgical procedures. Increasing geriatric population in China and Japan would open new market opportunities for carpal tunnel release system manufacturers looking to expand their business footprint.

Efficient, Evolved Surgery Procedures Fuelling Carpal Tunnel Release Systems Adoption

In the last few years, there has been an increase in carpal tunnel surgeries performed on out-patient surgeries owing to lower healthcare expenditure and better medical reimbursement coverage. This demand for carpal tunnel surgeries is attributable to the availability of effective and efficient products meant for CTR procedures. Key manufacturers of carpal tunnel release systems are collaborating with contract manufacturing organizations for developing efficient products according to treatment requirements. In terms of surgery methods, although cost-effective open surgical procedure for carpal tunnel release was previously the most preferred, efficiency and less risk associated with endoscopic procedures has led to an increased investment in this method, with key players like Stryker Corporation and Arthrex launching their range of endoscopic carpal tunnel release systems. Evolution of CTR surgeries with endoscopic methods has boosted the overall growth of carpal tunnel release systems market.

“Risks associated with carpal tunnel release surgeries could inhibit the growth of CTR systems to some extent. Nerve injury is the major risk associated with open surgery. Moreover, both, open and endoscopic methods have technical limitations. The invasive nature of both these methods and emergence of alternatives which do not require any incision would result in sluggish adoption of carpal tunnel release systems in the coming years”, Analyst, Healthcare Industry, Future Market Insights

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-5965

Acquisition, Product Innovation: Key Forward Strategy to Define Future Market Positions of Manufacturers

Leading manufacturers in the carpal tunnel release systems market are focusing on acquiring local manufacturers to expand their product portfolio and increase market share, developed and emerging markets. Manufacturers are also collaborating with hospitals and distributors to promote their CTR systems and expand regional presence, respectively. Increased research and development for a more focused product innovation and product enhancement would also drive the global carpal tunnel release systems market over the forecast period. Key manufacturer in the carpal tunnel release systems market are Arthrex, Smith & Nephew, CONMED Corporation, Integra LifeSciences Corporation, MicroAire Surgical Instruments, S.E.G-WAY Orthopaedics, Thayer Intellectual Property, and Sonex Health, LLC